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Abstract. Typhoid is an endemic in Fiji with increases observed since the early 2000s and frequent outbreaks
reported. We assessed the diagnostic accuracy of currently available typhoid rapid diagnostic tests (RDTs) (TUBEX,
Typhidot Rapid, and Test-It assay) to establish their performance against blood culture in Fiji and to examine their suit-
ability for rapid typhoid outbreak identification. The performance of RDTs was assessed in the public health reference
laboratory in Suva, Fiji, according to the manufacturers’ instructions. A simulation was used to examine the potential use
of RDTs for attribution of a febrile illness outbreak to typhoid. For the diagnostic evaluation, 179 patients were included;
49 had blood culture–confirmed typhoid, 76 had fever as a result of non-typhoid etiologies, and 54 were age-matched
community controls. The median (interquartile range) age was 29 (20–46) years. Of the participants, 92 (51.4%) were
male and 131 (73.2%) were indigenous Fijians. The sensitivities of the tests were 77.6% for TUBEX, 75.5% for Typhidot
Rapid, and 57.1% for Test-It assay. The Test-It assay had the highest specificity of 93.4%, followed by Typhidot Rapid
85.5% and TUBEX 60.5%. Typhidot Rapid had the best performance in the simulation for attribution of a febrile illness
outbreak to typhoid. Typhoid RDTs performed suboptimally for individual patient diagnosis due to low sensitivity and var-
iable specificity. We demonstrate that RDTs could be useful in the field for rapid attribution of febrile illness outbreaks to
typhoid. Typhidot Rapid had the best combination of sensitivity, specificity, positive and negative predictive values, cost,
and ease of use for this purpose.
INTRODUCTION
Typhoid is endemic in Fiji with increases observed since
2005.1,2 The disease is prevalent in peri-urban slums and
rural villages with localized outbreaks often associated with
flooding after cyclones2,3 or social gatherings such as funer-
als and weddings.4,5 Poor sanitation and consumption of
unsafe water and unwashed produce have been identified
as the risk factors for endemic typhoid.6,7 A serosurvey for
anti-Vi-antibody suggested that the prevalence of Salmo-
nella typhi exposure is much higher than that indicated by
culture-confirmed cases.8 Acute febrile illnesses such as
leptospirosis, dengue, and bacteremia because of patho-
gens other than S. typhi are also common in Fiji and may be
difficult to distinguish from typhoid.9,10 Blood culture is the
mainstay of typhoid diagnosis in Fiji, and none of the com-
mercially available typhoid rapid diagnostic tests (RDTs) are
currently in use in public health facilities. Establishing a
typhoid diagnosis in patients is essential because a delay in
starting effective antimicrobial treatment is a risk factor for
the development of severe and complicated disease, and
further transmission through prolonged shedding.11,12 Also,
rapid diagnosis will avoid delays in the public health
response to outbreaks of febrile illness, such as the applica-
tion of water, sanitation, and hygiene (WASH) activities or
vaccination, while the etiology is being established.
The diagnosis of typhoid is complicated by the lack of sen-
sitivity of existing methods.13 Blood culture is the most com-
mon method used and its sensitivity ranges from 40% to
66%.13–15 The volume of blood inoculated, and prior antimi-
crobial therapy, influence its performance. Blood culture
provides a definitive diagnosis, and yields an isolate for anti-
microbial susceptibility testing, but the length of time
required for blood culture to yield a result limits its value for
individual patient diagnosis and for the rapid attribution of
febrile illness outbreaks to typhoid. Several antibody detec-
tion RDT for typhoid are available, but their value for routine
individual patient management is limited by their lack of sen-
sitivity and specificity.13,16–20 Little attention has been given
to the use of typhoid RDTs in determining the etiology of a
febrile illness outbreak, a common public health problem in
Fiji and elsewhere. In typhoid outbreaks in Fiji, the number of
cases usually varies from 15 to 30 patients.4,21 When they
occur in an area remote to a blood culture service confirming
the diagnosis is a challenge. In such circumstances, an RDT
with inadequate sensitivity and specificity to guide individual
patient management might still be useful for rapid identifica-
tion of a typhoid outbreak because of the likelihood of a
common etiology for the outbreak and a larger number of
persons available for testing.
We evaluated the diagnostic accuracy of available typhoid
RDTs on stored serum samples from patients and subjects
in Fiji. We then sought to examine if any are suitable to rule
in or out typhoid as the cause of an outbreak.
MATERIALS AND METHODS
Study setting. Fiji is an archipelago in the South Pacific
Ocean. According to the 2017 census, the Fiji population
was 884,887.22 Most of the population reside on the islands
of Viti Levu, where the capital Suva is located, and Vanua
Levu. Indigenous Fijians or i-Taukei represent 57% of the
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population, with Fijians of Indian Decent 37% and other eth-
nicities 6%.23
Health services are provided mainly by the Ministry of
Health and Medical Services (MoHMS). There are four health
divisions: Central, Western, Northern, and Eastern. Each
division is further divided into subdivisions, medical areas,
and then zones. There are 3 divisional hospitals and 2 spe-
cialist hospitals, 19 subdivisional hospitals, and 86 health
centers.24
Study subjects.We conducted a retrospective diagnostic
accuracy study using stored serum samples. Cases were
patients with blood culture–confirmed typhoid diagnosed
from the Central division of Fiji from March through August
2016. Controls were patients with febrile illness enrolled dur-
ing the same period as cases, from the Central, Northern,
and Western Divisions of Fiji, in the following four groups:
those with bacteremia as a result of bacterial pathogens
other than S. typhi confirmed by blood culture, leptospirosis
confirmed by Leptospira IgM enzyme-linked immunosorbent
assay (ELISA) (Leptospira IgM Standard Diagnostics, Yongin-
si, South Korea), dengue confirmed by NS1 antigen or IgM
ELISA (Dengue Duo, Dengue NS1 Ag1AB combo, Standard
Diagnostics, Yongin-si, South Korea), and febrile patients with
negative blood culture and serologic tests for leptospirosis
and dengue. For community controls, we randomly selected
serum samples of individuals who participated in the 2013
population-based serosurvey. Community controls reported
no history of fever at the time of the survey and had not been
diagnosed with typhoid in the 12 months before the survey.8
Samples for community controls were matched by age 6 5
years to typhoid cases in this study. The level of anti-Vi IgG
antibody levels were determined for the community controls
as part of the previous survey.8 The purpose of the commu-
nity controls was to indicate the background levels of anti-
bodies in the Fiji population as determined by the RDTs.
Laboratory procedures. Blood cultures and serum sam-
ples were collected from febrile patients with suspected
infection as a part of routine clinical care. The blood cultures
were processed using a BaCT/ALERT 3D (Biomerieux,
Marcy L’Etoile, France) system at the Colonial War Memorial
Hospital (CWMH), the main hospital in Fiji’s capital, Suva.
Serology testing for leptospirosis and dengue were con-
ducted at Fiji national public health reference laboratory
according to the manufacturer’s instructions. Residual
serum samples of cases and controls archived at 220C or
280C in CWMH and public health reference laboratory
were used for testing.
Typhoid rapid diagnostic tests. Serum samples were
thawed, and an aliquot was transferred to a new tube. The
samples were then de-identified according to a computer-
generated randomization code and relabeled with a study
number so that the laboratory staff testing the samples
would be blind to the original diagnosis. The three RDTs
included in this study were TUBEXVR test (IDL Biotech AB,
Bromma, Sweden), Typhidot Rapid IgM test (Reszon Diag-
nostics International Sdn Bhd, Malaysia), and Test-ItTM
Typhoid IgM test (Life Assay Diagnostics (Pty), Cape Town,
South Africa). The TUBEX test is an inhibition magnetic bind-
ing immunoassay that detects S. typhi anti-09 IgM antibod-
ies in patient’s serum. The semiquantitative colorimetric
reading is given a score between 0 and 10 with a score $ 4
positive and a score of # 2 negative. A score between two
and four was considered indeterminate. If the serum is
hemolyzed, it is not possible to determine the color. The
Typhidot Rapid IgM test is a lateral flow assay that detects
IgM antibodies against an outer membrane protein of
S. typhi. A test line, in combination with a control line, is con-
sidered as a positive result. The Test-ItTM Typhoid IgM test
is also a lateral flow assay that detects IgM antibodies
against the lipopolysaccharide antigen of S. typhi. A test
line, in combination with a control line, is considered as a
positive result. The test line is scored 11 to 41 according to
the intensity of the line.
The samples were tested in the Fiji national public health
reference laboratory from September 7 to 23, 2016, using
the RDTs according to the manufacturers’ instructions by
laboratory personnel, trained in the use of all tests. Each test
result was read independently by two separate observers to
determine the inter-rater agreement. The tests were ran-
domly relabeled and examined again by one of the observers
to assess the intra-rater agreement. Information about the
test characteristics, including sample volume, consumable
required, storage, and cost for each test was recorded. Lab-
oratory personnel also provided further details on ease to
perform and interpret results. As the RDT’s will be used in
the field, we classified the ease of use depending on the
practicality of the tests, how much training would be
required before use in the field, and the need for additional
laboratory supplies or equipment. For visual interpretation,
we assessed how recognizable are color changes or the
positivity marker and any discrepancy of results between
laboratory personnel. RDTs were reported as easy to use or
interpret if testing procedures and results were straightfor-
ward or uncomplicated and no additional training is needed;
moderate if some problems and confusion occurred during
testing or interpretation; or difficult if tests required several
steps to perform or complex to interpret due to indetermi-
nate or unclear results or if extra skill or equipment are
needed for testing or interpretation of results.
Sample size. We included samples from participants col-
lected from March through August 2016 and determined the
precision of sensitivity and specificity estimates based on
the available sample size. Conservatively assuming the
RDTs have a sensitivity of 60%, a sample size of 49 typhoid-
positive cases would produce a sensitivity estimate with a
two-sided 95% CI using the normal approximation of width
613.7%. Similarly, assuming a specificity of 60%, 76
typhoid negative cases would produce a two-sided 95% CI
of width 611%. Higher sensitivity and specificity values
would result in narrower CIs.
Statistical analysis. Data were entered into Microsoft
Excel (Microsoft Corporation, Redmond, WA) for analysis.
Sensitivity, specificity, positive predictive value (PPV), and
negative predictive value (NPV) were calculated for each
RDT using standard methods.25,26 This analysis assumed
that a positive blood culture is the reference standard for
typhoid diagnosis. That is, the cases with culture-confirmed
typhoid and febrile controls were the reference standard
positives and negatives, respectively. For the calculation of
PPV and NPV, the background disease prevalence was set
at 20% based on the blood culture positivity rate in health
facilities.27 Intra-rater and inter-rater agreement for the RDT
result was determined using the Kappa statistics.25,28 Calcu-




agreement, . 0.20 and # 0.40 fair agreement, .0.40
and #0.60 moderate agreement, . 0.60 and #0.80 good
agreement, and .0.80 very good agreement.25,28,29 Intra-
observer reproducibility was determined by comparing the
RDT result for each observer with their RDT result on a sepa-
rate reading. Inter-observer reproducibility was determined
by pairing the RDT result by each observer with that of the
other observer. Age and Vi IgG levels in community controls
positive and negative by typhoid RDTs were compared by
the Kruskal–Wallis test.
We also examined the use of binomial trials for attributing
a febrile illness outbreak to typhoid.30 This involved using
binomial distributions to estimate the probabilities of observ-
ing a certain number of typhoid-positive tests by chance
alone. A simulation was used to assess the operating char-
acteristics of the RDTs, and to examine their potential use in
a typhoid outbreak. In the simulations, we created datasets
of size N 5 15 patients, which was considered to be a realis-
tic number of patients seen and tested when doing a field
visit to a village in Fiji during a suspected outbreak. We
assumed that, in the absence of an outbreak, the underlying
background prevalence of typhoid among febrile patients
was 10%. We also assumed that an outbreak would be
declared if six or more patients (i.e., $ 40%) tested posi-
tive by any method for typhoid. In the simulations, the
number of positive tests by blood culture (npos) were var-
ied from 1 to 14. The true positives (TP) were drawn from
a binomial distribution, TP Binomialðnpos, SensitivityÞ.
The true negatives (TN) were drawn from a binomial dis-
tribution, TN Binomialð15 npos, Specificity). For the
simulations, we used the sensitivity and specificity esti-
mates observed in our study. For each scenario, 2,000
datasets were generated, and the following data were
collected: the number of positives for each RDT, and
whether a typhoid outbreak would have been declared
based on a threshold of six positives.
This study received ethics approval from the Fiji National
Health Research Ethics Review Committee (2016.63NW).
The laboratory testing was performed on anonymized stored
serum samples, which have been collected as part of routine
clinical care. The defined clinical syndrome, age, and sex
data were obtained from the laboratory forms. There was no
contact with patients, so no consent was taken.
RESULTS
Of 179 total participants, 92 (51.4%) were male and 131
(73.2%) were from i-Taukei ethnic group (Indigenous Fijians).
The median (interquartile range [IQR]) age was 29 (20–46)
years. The demographic profiles of cases and controls are
shown in Table 1. Of the 179 participants, 49 (27.4%) had
blood culture–confirmed typhoid, 76 (42.5%) had fever due
to another or unknown etiology, and 54 (30.2%) were age-
matched community controls. Among 76 participants with
fever other than typhoid, 24 (31.6%) had dengue fever, 24
(31.6%) leptospirosis, 2 (2.6%) mixed dengue and leptospi-
rosis infection, 14 (18.4%) bacteremia other than S. typhi
(Escherichia coli (N 5 5), Staphylococcus aureus (N 5 4),
b-hemolytic streptococci (N5 2), and one case each of Can-
dida species, Enterobacter cloacae, and Serratia marces-
cens), and 12 (15.8%) were blood culture and serology test
negative. Of the 49 typhoid cases, 24 had a leptospirosis
IgM positive or dengue NS-1 or IgM positive result, suggest-
ing possible coinfection. In the face of a positive blood cul-
ture for S. typhi, these may represent false positive results
due to previous exposure.
Table 2 shows the characteristics of the three RDTs used
in the study. The TUBEX test is a semiquantitative test that
came with one positive and one negative control as well as
detector and indicators reagents. The kit did not include
consumables; therefore, additional supplies and equipment
are needed to perform the test. Our laboratory staff found
that the TUBEX test was technically more challenging to per-
form. Furthermore, the color endpoint of the TUBEX reaction
was difficult to read, particularly if there was any hemolysis
of the sample. This difficulty led to one in five results being
indeterminate using TUBEX. The Typhidot Rapid and Test-It
assay are simple lateral flow tests that were easy to perform
and interpret. The intra-rater and inter-rater agreement by
Kappa testing were 0.77 and 0.79 for TUBEX, 0.82 and 0.97
for Typhidot Rapid, and 0.87 and 0.95 for the Test-It assay.
Of the total of 125 samples tested from participants with
fever, 68 (54.4%) were positive by TUBEX, including 38
(77.6%) of 49 samples from typhoid cases and 30 (39.5%) of
76 samples from febrile controls, 48 (75.5%) were positive
with Typhidot Rapid, including 37 (75.5%) of typhoid cases
and 11 (14.5%) of febrile controls, and 33 (51.1%) positive
with Test-It assay, including 28 (57.1%) of typhoid cases
and 5 (16.6%) of febrile controls. The overlap of the RDT
results in the confirmed positive cases is shown in Figure 1.
There were 27 (21.6%) indeterminate results with the
TUBEX, 9 (7.2%) with Typhidot Rapid, and 4 (3.2%) with the
Test-It assay. In the febrile cases that were blood culture
negative, there were two patients who were positive on two
of the three RDTS and two that were positive with all three
RDTs. These may have been misclassified patients with
blood culture–negative typhoid fever.
For the community controls, nine (16.7%) tested positive
with TUBEX and seven (13.0%) with Typhidot Rapid. The
Test-It assay was negative in all community controls. The
median (IQR) age of the community controls with a positive
RDT (either TUBEX or Typhidot Rapid) was 35 (26–55) years
compared with 25 (17–35) years for those with a negative
RDT (P 5 0.02). The median (IQR) anti-Vi IgG level of the
community controls with a positive RDT (either TUBEX or
Typhidot Rapid) was 65.4 (33.9–143.1) ELISA units com-
pared with 39.0 (21.4–89.1) ELISA unit for those with a nega-
tive RDT (P5 0.33).
The sensitivity and specificity of the three RDTs using
blood culture–confirmed typhoid cases as the reference
standard are shown in Table 3. Table 3 also shows the PPV
and NPVs of the different RDTs assuming a disease preva-
lence of 20%.27 TUBEX had a sensitivity of 77.6%, specific-
ity 60.5%, with a PPV of 32.2%, and NPV of 91.5%. The
sensitivity, specificity, PPV, and NPV of Typhidot Rapid were
75.5%, 85.5%, 56.6%, and 93.3%, respectively. The Test-It
assay had a sensitivity of 57.1%, specificity 93.4%, PPV
68.5%, and NPV 89.7%.
We examined the use of binomial trials to attribute a febrile
illness outbreak to typhoid. Supplemental Table 1 shows the
binomial probabilities for one illustrative scenario where 15
febrile patients were tested, with a background typhoid prev-
alence of about 10%. The results indicate, for example, that
in the absence of an outbreak, there is a probability of 0.002
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(i.e.,, 1/100) that six or more of these cases will have a pos-
itive test by chance alone. Therefore, a threshold of six or
more positive cases could be used to raise a red flag
that a typhoid outbreak is occurring, given it is very unlikely
(, P5 0.01) that this would occur by chance.
The results of the simulation exercise are in Table 4 using
the sensitivity and specificity estimates observed in our
study. The low specificity of TUBEX resulted in a large num-
ber of false positives. For example, when there was only one
TP case, on average six patients would test positive by the
TUBEX test, resulting in an outbreak being declared in 68%
of the 2,000 simulations even when there was no outbreak.
In contrast, the Test-It method failed to detect many of the
TP cases as a result of its low sensitivity. For example, when
TABLE 1
Demographic profile of cases and controls, Fiji, 2016
Demography Total N 5 179 Typhoid cases N 5 49 Febrile controls N 5 76 Community controls N 5 54
Age (median [IQR]) 29 (20.0–46.0) 24.5 (16.3–35.5) 37 (25.0–56.0) 26 (18.82 30.6)
Sex (n, % male) 92 (51.4) 24 (49.0) 43 (56.6) 25 (46.3)
Ethnicity (n, %, i-Taukei) 131 (73.2) 47 (95.5) 41 (53.9) 43 (79.6)
IQR5 interquartile range.
TABLE 2
Characteristics of typhoid rapid diagnostic tests used in the study, Fiji, 2016
Characteristics TUBEXV
R
TF, (IDL Biotec) Typhidot Rapid (Reszon Diagnostic) Test-ItTM (Life Assay Diagnostics)
Assay and sample
Target Salmonella typhi IgM anti-09
antibodies
IgM antibodies to a 50 kDa
Salmonella typhi outer
membrane protein
IgM antibodies to Salmonella
enterica LPS






Sample volume 45mL 30mL serum/plasma,
35mL whole blood
5mL
Kit components (per box)
Number of tests 36 25 individual cassettes 25 individual cassettes
Number of controls Positive and negative control
included in the kit
Not included (optional) Not included
Consumables No consumables included No consumables included All required consumables
included
Reagents Detector reagent, Indicator
reagent. Wash buffer for
hemolyzed samples optional.
Chase buffer One bottle running fluid
Storage temperature (C)
Kit 2–28 4–30 4–28
Individual cassette N/A 4–30 up to 45 for 2 months
Procedure
Preparation time (per test
run approx. 10 samples)
10–15 minutes 15 minutes 5–10 minutes
Incubation time (per test) 10 minutes 10 minutes (serum/plasma),




, 1 minute , 1 minute , 1 minute
Ease of use Moderate Easy Easy
Result interpretation
Method of interpretation Visual color interpretation The visual presence of a test
line
The visual presence of a test
line
Result score Semiquantitative. 0 (negative) to
10 (strongly positive)






30 minutes Not stated 30 minutes




Internal kit control None Individual cassette control line Individual cassette control line
and desiccant
Positive/negative controls One positive and one negative
control per run
Not included Not included
Intra-rater Kappa 0.77 (0.67–0.86) 0.82 (0.73–0.91) 0.87 (0.78–0.97)
Inter-rater Kappa 0.79 (0.70–0.88) 0.97(0.94–1.00) 0.95 (0.89–1.00)
Cost
Cost per test (USD) 3.1 2.2 2.0
Can be used in the field? Yes. But more complicated than
simple lateral flow RDTs
Yes. Simple lateral flow and can
be used with finger-prick
sample
Yes. Simple lateral flow and can
be used with finger-prick
sample




there were nine TP cases, the Test-It declared an outbreak
in only 52% of simulations. The higher specificity of the
Test-It method could potentially allow a smaller number of
positives to be used as the threshold for declaring an out-
break. On balance, Typhidot had the best performance, with
the median number testing positive being most similar to the
correct number of positive cases. If there were one, six, and
nine TP cases, the Typhidot declared an outbreak in 3.5%,
61%, and 92% of simulations (Table 4, column 5).
DISCUSSION
We assessed the diagnostic accuracy of the three
RDTs for typhoid and examined their potential for use in
the field setting for rapid outbreak identification in Fiji.
Overall, the RDT’s performance was suboptimal, but
could be used to correctly declare a typhoid outbreak if
interpreted with care.
TUBEX had the highest sensitivity of 77.6%, but with a
specificity of 60.5%, and PPV of 32.9%. The specificity of
Test-It assay was the highest among all the tests at 93.4%.
Moreover, the Test-It positive and NPVs were 68.5% and
89.7%, but its sensitivity was , 60%. Typhidot Rapid per-
formed relatively well with specificity and sensitivity above
75% but PPV 56.6%. When tested on serum from community
controls, TUBEX and Typhidot Rapid gave positive results in
16.7% and 13.0% of subjects, respectively, whereas Test-It
assay gave no positive results. Community controls with a
positive RDT result tended to be older, and with a higher level
of anti-Vi IgG antibodies than those with a negative result,
suggesting that prior typhoid may contribute to these positive
results. The above findings suggest that none of the RDTs
have sufficient accuracy to recommend them for individual
patient diagnosis.
Our findings on the performance of Typhidot Rapid and
Test-It assay are comparable to a recent systematic review,
which reported sensitivity of 78% (95% CI 65–81) and
69 (95% CI 59–78) and specificity of 77 (95% CI 66–86) and
90 (95% CI 78–93), respectively.20 In our study, TUBEX sen-
sitivity was similar to that found by the systematic review.
TUBEX specificity was lower, at 60.5% (95% CI 49.5–71.5),
in our study compared with the systematic review specificity
of 87% (95% CI 82–91), and a study in Vietnam 94% (95%
CI 71–100).31 A lower level of TUBEX specificity 69%
(CI 95% 49.2–84.7) was also reported from a study in sub-
Saharan African countries.16 Direct comparison of the diag-
nostic test performance could not be made as there are
methodological differences between the studies as well as
the level of typhoid endemicity. Repeated exposure or recent
S. typhi infection could be one of the reasons for the lower
specificity and high rate of false positivity of TUBEX in Fiji.
Outbreaks of typhoid in the community are frequent in
Fiji.4,21,32,33 The number of outbreak-related typhoid cases
varies from 15 to 30 patients. For example, after the Tropical
Cyclone Winston, which hit Fiji on February 20, 2016, the
MoHMS reported a total of 25 laboratory-confirmed cases
and 26 suspected cases in Qelekuro and neighboring vil-
lages in the Central division, Tailevu subdivision, during
1-month period from March through April 2016. Blood cul-
ture is the only confirmatory test for typhoid in Fiji, and it is
available in the three divisional-level hospitals. Therefore, a
large outbreak of febrile illness of unknown etiology in an
area remote to a blood culture service poses a major chal-
lenge for confirmation of the diagnosis. In this study, we
have used a simulation exercise, using the binomial method,
to identify a suitable alternative test for the rapid detection of
an outbreak. We examined hypothetical situations of 15
febrile cases with variable true prevalence of typhoid. Our
simulations demonstrated that Typhidot Rapid test per-
formed better than the other RDTs in the outbreak simulation
scenario declaring an outbreak in 61% of simulations when
the threshold of six TP cases had been reached. TUBEX
overcalled outbreaks and Test-It assay undercalled them. If
the threshold for declaring an outbreak was lower than six
TP, the higher specificity of the Test-It method might also
allow it to be used. The results suggest that the Typhoidot
Rapid test and the Test-It method may have a potential use
during a suspected typhoid outbreak in the investigation in
the community. We could have proposed a more liberal
FIGURE 1. Positive results for each rapid diagnostic test (RDT) for
the 49 patients with confirmed blood culture positive typhoid fever.
TABLE 3
















value % (95% CI)
TUBEX 38/49 30/76 77.6 (63.4–88.2) 60.5 (48.6–71.6) 32.9 (26.4–40.3) 91.5 (86.1–94.9)
Typhidot Rapid 37/49 11/76 75.5 (61.1–86.7) 85.5 (75.6–92.5) 56.6 (42.5–69.7) 93.3 (89.4–95.8)
Test-It Assay 28/49 5/76 57.1 (42.2–71.2) 93.4 (85.3–97.8) 68.5 (47.4–84.0) 89.7 (86.3–92.4)
The positive and negative predictive values were calculated assuming a disease prevalence of 20%.
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threshold for declaring an outbreak (e.g., 5/15), but run the
risk of declaring more frequent false positive outbreaks. The
detection of potential outbreaks might be followed up by
more definitive blood culture testing in a two-step process.
Our laboratory staff found that the TUBEX test was techni-
cally more challenging to perform than the Typhidot Rapid
and Test-It assays. The intra-rater and inter-rater agreement
were slightly less for TUBEX, compared with the Typhidot
Rapid and Test-It assays, and the cost is higher. The intra-
and inter-Kappa for both tests were . 80% indicating very
good reproducibility of results by the individual observer as
well as with that of other observers. Test-It assay included
all required consumables making it the most convenient and
cheapest of all the three tests we evaluated.
Our study has limitations. We used blood culture as a gold
standard for typhoid diagnosis, despite its limited sensitivity.
Some typhoid patients may have been misclassified as
non-cases by blood culture, incorrectly classifying some
RDT-positive participants false positive. Four of the febrile
controls with a negative blood culture were positive by two or
three of the RDTs and may represent such misclassifications.
Another limitation is the design with previously collected
cases and controls, rather than consecutive patients present-
ing with fever, and the small number of patients included in
the study. The ELISA tests used for leptospirosis and dengue
do not have perfect sensitivity and specificity, which may
have resulted in misclassification of febrile controls.
In conclusion, the performance of the typhoid RDTs was
generally suboptimal with low sensitivity (less than 80%) and
variable specificity (60–93%). Although we do not recom-
mend their use in Fiji for patient-level diagnosis of typhoid,
they may be useful in the field investigation of outbreaks of
febrile illness for rapid assessment of typhoid as a cause. Of
the three assays evaluated, Typhidot Rapid had the best
combination of sensitivity, specificity, PPV, NPV, cost, and
ease of use for this purpose, but further evaluations of its
use in the field are required.
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TABLE 4
Results of the simulation exercise for the results of the three typhoid RDTs performed on 15 subjects who form part of an outbreak of a
febrile illness for attribution of the outbreak of febrile illness to typhoid
Number of true
positive cases out of
15 (i.e., assumed to be
correct value in the
simulations)
Typhoid Rapid Diagnostic Test
TUBEX Typhidot Rapid Test-It
Number of positive








results out of 15*
Proportion declared a
typhoid outbreak†
1 6 0.678 3 0.035 1 0
2 7 0.753 3 0.068 2 0.006
3 7 0.803 4 0.145 2 0.012
4 7 0.861 5 0.263 3 0.031
5 8 0.897 5 0.418 3.5 0.070
6 8 0.934 6 0.614 4 0.150
7 9 0.967 6 0.754 4 0.249
8 9 0.972 7 0.853 5 0.383
9 9 0.985 8 0.919 6 0.523
10 10 0.989 8 0.964 6 0.632
11 10 0.995 9 0.977 7 0.729
12 11 0.998 9 0.990 7 0.802
13 11 0.998 10 0.995 8 0.876
14 11 1 11 0.998 8 0.905
RDT5 rapid diagnostic test. The number of true positive required to declare an outbreak is set at 6 or more.
*Results shown are median numbers of tests declared positive, calculated overN5 2,000 simulated datasets each consisting of 15 patients.
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